Orthopedic, Musculoskeletal & Spine Segment to Lead Tissue Engineering Market During 2022-2028

According to our new research study, titled "Tissue Engineering Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Material Type (Synthetic Material, Biologically Derived Materials, and Others), Application (Orthopedic, Musculoskeletal and Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, Urology, GI & Gynecology, Cancer, and Others), and Geography," the tissue engineering market is projected to grow from US$ 13,236.87 million in 2022 to US$ 29,659.93 million by 2028. It is estimated to grow at a CAGR of 12.2% from 2022 to 2028. The report highlights the key factors driving the market and prominent payers' developments.

The rising incidences of chronic diseases, road accidents and trauma injuries, and technological advancements in 3D tissue engineering are driving the growth of the global tissue engineering market. However, the high cost of treatments related to tissue engineering is hindering the market's growth.

Tissue engineering is a technique used as a combination of material methods and cells. Also, this technique follows the physicochemical and biochemical factors to replace and improve the biological tissues. It is an exciting strategy that works on the scaffolds, stem cells, regenerative medicine, and growth factors or negotiators, either in isolation or in combination. The technique uses molecular and cellular methods combined with material engineering principles to restore tissue surgically.

3D bioprinting has rapidly transformed the healthcare sector in the last few years. This technology has advanced tissue development with clinical potential, paving the way for high-throughput applications for drug discovery. 3D bioprinting tissue engineering helps heal injuries, and new breakthroughs in the 3D printing technique are projected to offer a potential treatment option for organ failure in the near future.

Many research organizations are working toward finding new therapies to treat organ failure and repair cells of damaged tissues. For instance, in 2017, researchers at Penn State University discovered a revolutionary way to print tissues and organs using an "electrospinning printer" that spins fibers seeded with cells to create fiber layers. This technology is cheaper and offers an opportunity to spin polymer fibers, such as collagen layers, with precision and control.

In addition to this, scientists at George R. Brown School of Engineering reported the construction of a 3D-printed organ that mimics lungs. In April 2019, a researcher at Tel Aviv University printed the world's first 3D-engineered, vascularized heart using a patient's cells and biological materials. Furthermore, highly mimicked tissues or organs can be engineered with advances in stem cell research, intelligent biomaterials, and three-dimensional biofabrication strategies. Future advances in bioprinting include the integration of different printing mechanisms to produce biphasic or triphasic tissues with optimized scaffolds and a further understanding of stem cell biology.

3D printing has promised tissue manufacturing with micro- to macro-scale structural control through a layer-by-layer approach. Through 3D reconstructions of scanned lesions, bioprinting can precisely deliver cells, growth factors, and biomaterial scaffolds to repair the lesion with different shapes and thicknesses. A promising direction is to combine the bioprinting approaches based on other mechanisms to meet the various challenges. Increasing government funding for research activities is expected to enhance the growth of the global tissue engineering market. For instance, as per the National Institutes of Health (NIH) funding study in the US, the research studies about stem cell and regenerative medicines received funding of US$ 1.8 and US$ 1.0 billion, respectively, in 2018.

Based on application, the global tissue engineering market is segmented into orthopedic, musculoskeletal & spine, neurology, cardiology & vascular, skin & integumentary, urology, GI & gynecology, cancer, and others. The orthopedic, musculoskeletal & spine segment will account for the largest share of the market in 2022, while the skin & integumentary segment is estimated to register the highest CAGR of 13.4% in the market during the forecast period.

The tissue engineering technique plays a vital role in orthopedic, musculoskeletal & spine areas due to the familiarity with mesenchymal stem cells that can be derived from the bone marrow. Many musculoskeletal tissues are frequently damaged due to the injury caused by fracture nonunion, osteochondral defects, and osteonecrosis. During these conditions, the musculoskeletal tissues show limited capacity for repair. The tissue engineering technique is successfully used in solving these major issues by replacing cartilage in orthopedic, musculoskeletal, and spine surgeries.

From the total joint replacement to the use of recombinant human bone morphogenetic protein-2, biomedical engineers and orthopedic surgeons have worked together to generate novel strategies such as mechanical devices or allograft materials to replace and repair damaged tissues. In recent years, the treatment of orthopedic and musculoskeletal-related injuries has shifted toward regenerating functional tissues using autologous cells obtained from patients themselves. This method could eliminate the problems of graft rejection and mechanical device failure.

Stryker Corporation, Organogenesis Inc., Cook Biotech Inc., Integra Life Sciences Corporation, 3M, Abbvie., Medtronic, Zimmer Biomet, Baxter International Inc., DePuy Synthes (Johnson & Johnson Services, Inc.), and B. Braun Melsungen AG the key companies operating in the global tissue engineering market.

The report segments the global Tissue Engineering market as follows:

The global tissue engineering market is analyzed on the basis of material type, application, and geography. Based on material type, the market is segmented into synthetic material, biologically derived materials, and others. Based on application, the global tissue engineering market is segmented into orthopedic, musculoskeletal & spine, neurology, Cardiology & Vascular, Skin & integumentary, urology, GI & Gynecology, cancer, and others. By geography, the global Tissue Engineering market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com